Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Free Report) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totalling 25,800 shares, a decline of 37.4% from the November 30th total of 41,200 shares. Based on an average trading volume of 96,300 shares, the short-interest ratio […]